0001878646-22-000047.txt : 20221014 0001878646-22-000047.hdr.sgml : 20221014 20221014114618 ACCESSION NUMBER: 0001878646-22-000047 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221014 DATE AS OF CHANGE: 20221014 EFFECTIVENESS DATE: 20221014 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Neuraptive Therapeutics, Inc. CENTRAL INDEX KEY: 0001713836 IRS NUMBER: 821914769 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-461750 FILM NUMBER: 221310657 BUSINESS ADDRESS: STREET 1: TWO LOGAN SQUARE STREET 2: SUITE 1930 CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: 484-787-3203 MAIL ADDRESS: STREET 1: TWO LOGAN SQUARE STREET 2: SUITE 1930 CITY: PHILADELPHIA STATE: PA ZIP: 19103 D 1 primary_doc.xml X0708 D LIVE 0001713836 Neuraptive Therapeutics, Inc. TWO LOGAN SQUARE SUITE 1930 PHILADELPHIA PA PENNSYLVANIA 19103 484-787-3203 PENNSYLVANIA None None Corporation true Robert S Radie Two Logan Square Suite 1930 Philadelphia PA PENNSYLVANIA 19103 Executive Officer Director Evan Tzanis Two Logan Square Suite 1930 Philadelphia PA PENNSYLVANIA 19103 Executive Officer Ivan Gergel Two Logan Square Suite 1930 Philadelphia PA PENNSYLVANIA 19103 Director David Jackson Two Logan Square Suite 1930 Philadelphia PA PENNSYLVANIA 19103 Director Greg Parekh Two Logan Square Suite 1930 Philadelphia PA PENNSYLVANIA 19103 Director David Pierce Two Logan Square Suite 1930 Philadelphia PA PENNSYLVANIA 19103 Director Randy Hubbell Two Logan Square Suite 1930 Philadelphia PA PENNSYLVANIA 19103 Director Biotechnology Decline to Disclose 06b false 2022-09-29 false true true true false 25000 Maxim Group LLC 120708 None None 300 Park Avenue New York NY NEW YORK 10022 All States false 38132939 19490348 18642591 false 71 1125740 0 Placement Agent Fee 0 false Neuraptive Therapeutics, Inc. /s/Robert S. Radie Robert S. Radie Chairman and CEO 2022-10-14